Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4
Perspectives
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,216 | Dovepress* | 10,003+ | 2,084 | 12,087 | |
PubMed Central* | 1,213 | 421 | 1,634 | ||
Totals | 11,216 | 2,505 | 13,721 | ||
*Since 6 December 2012 +Since July 2016 |
View citations on PubMed Central and Google Scholar